ArticleScientific reports2020

Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management.

Pil Hyung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.